Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 1;23(3):1685.
doi: 10.3390/ijms23031685.

Nanoparticles in Clinical Translation for Cancer Therapy

Deepa Mundekkad  1 , William C Cho  2
Affiliations
Review

Nanoparticles in Clinical Translation for Cancer Therapy

Deepa Mundekkad et al. Int J Mol Sci. .

Abstract

The advent of cancer therapeutics brought a paradigm shift from conventional therapy to precision medicine. The new therapeutic modalities accomplished through the properties of nanomaterials have extended their scope in cancer therapy beyond conventional drug delivery. Nanoparticles can be channeled in cancer therapy to encapsulate active pharmaceutical ingredients and deliver them to the tumor site in a more efficient manner. This review enumerates various types of nanoparticles that have entered clinical trials for cancer treatment. The obstacles in the journey of nanodrug from clinic to market are reviewed. Furthermore, the latest developments in using nanoparticles in cancer therapy are also highlighted.

Keywords: cancer therapy; nanochemotherapy; nanodrugs; nanomedicine; nanoparticles.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Mechanisms of cell death in cancer induced by nanoparticles.
Figure 2
Figure 2
Phototherapy is used to induce apoptosis in cancer cells by employing light, heat, and radiation. Photosensitizers like nanoparticles enhance the killing effect by targeting signaling pathways and the immune system.
Figure 3
Figure 3
Different types of nanomedicines that are used for the treatment of cancer.
Figure 4
Figure 4
(A) Various forms of liposome-based nanomedicines. The variety of formulations under the category specifies the flexibility of the liposomes for the formulation of nanodrugs. The number in parenthesis refers to the number of drugs that are approved and under trial respectively, under each category. (B) Major FDA approved nanochemotherapeutic drugs based on liposomes. (C) Some of the liposome-based nanochemotherapeutic drugs that are under clinical trial.
Figure 5
Figure 5
Nanochemotherapeutic drugs that are based on metal and metal oxides, polymeric micelles, polymer/lipids, and other conjugates. (The formulations inside the circle are approved and those outside are under trial).
Figure 6
Figure 6
Schematic representation of the drug targeting strategies followed to deliver therapeutic molecules to cancer cells. The various modes of drug delivery ensure that the drug is effectively delivered to the cells of interest and thus, unwanted damage to normal cells can be minimized.
See this image and copyright information in PMC

References

    1. Rhodes K.R., Green J.J. Nanoscale artificial antigen presenting cells for cancer immunotherapy. Mol. Immunol. 2018;98:13–18. doi: 10.1016/j.molimm.2018.02.016. - DOI - PMC - PubMed
    1. Wang J., Li Y., Nie G. Multifunctional biomolecule nanostructures for cancer therapy. Nat. Rev. Mater. 2021;6:766–783. doi: 10.1038/s41578-021-00315-x. - DOI - PMC - PubMed
    1. Sun T., Zhang Y.S., Pang B., Hyun D.C., Yang M., Xia Y. Engineered nanoparticles for drug delivery in cancer therapy. Angew. Chem. Int. Ed. 2014;53:12320–12364. doi: 10.1002/anie.201403036. - DOI - PubMed
    1. Hassan H.A.F.M., Smyth L., Wang J.T.-W., Costa P.M., Ratnasothy K., Diebold S.S., Lombardi G., Al-Jamal K.T. Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy. Biomaterials. 2016;104:310–322. doi: 10.1016/j.biomaterials.2016.07.005. - DOI - PMC - PubMed
    1. Yetisgin A.A., Cetinel S., Zuvin M., Kosar A., Kutlu O. Therapeutic nanoparticles and their targeted delivery applications. Molecules. 2020;25:2193. doi: 10.3390/molecules25092193. - DOI - PMC - PubMed

LinkOut - more resources